Novel Drug Shrinks 73% of HER2-Mutant Lung Cancers

(MedPage Today)-Anti-investigating drugs are compared to active and safe drugs for patients with non-cell lung cancer treated by Her2 (NSCLC). From 94 patients with local progress …